These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28254185)

  • 1. Objectively Measured Adherence to Physical Activity Guidelines After Acute Coronary Syndrome.
    Kronish IM; Diaz KM; Goldsmith J; Moise N; Schwartz JE
    J Am Coll Cardiol; 2017 Mar; 69(9):1205-1207. PubMed ID: 28254185
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with objectively measured exercise participation after hospitalization for acute coronary syndrome.
    Goodwin AM; Duran AT; Kronish IM; Moise N; Sanchez GJ; Garber CE; Schwartz JE; Diaz KM
    Int J Cardiol; 2019 Jan; 275():1-5. PubMed ID: 30391064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Prescribing Gap For Guideline Recommended Medications Post Myocardial Infarction.
    Wilkins B; Hullikunte S; Simmonds M; Sasse A; Larsen P; Harding SA
    Heart Lung Circ; 2019 Feb; 28(2):257-262. PubMed ID: 29523466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.
    Ergatoudes C; Thunström E; Rosengren A; Björck L; Bengtsson Boström K; Falk K; Fu M
    BMC Cardiovasc Disord; 2016 Nov; 16(1):226. PubMed ID: 27855640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice.
    Kassab YW; Hassan Y; Aziz NA; Akram H; Ismail O
    J Eval Clin Pract; 2013 Aug; 19(4):658-63. PubMed ID: 22845427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARTphone-based, early cardiac REHABilitation in patients with acute coronary syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol.
    Yudi MB; Clark DJ; Tsang D; Jelinek M; Kalten K; Joshi S; Phan K; Nasis A; Amerena J; Arunothayaraj S; Reid C; Farouque O
    BMC Cardiovasc Disord; 2016 Sep; 16(1):170. PubMed ID: 27596569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary prevention after acute coronary syndrome: are dyslipidaemia guideline targets achieved?
    Martins de Carvalho M; Proença T; Alves Pinto R; Rodrigues J; Rocha A; Dias P; Macedo F
    Eur J Prev Cardiol; 2022 Mar; 29(3):e122-e124. PubMed ID: 34097035
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to Cardio-protective Medications Prescribed for Secondary Prevention after an Acute Coronary Syndrome Hospitalization Compared to Usual Care.
    Rana JS; Parker MM; Liu JY; Moffet HH; Karter AJ
    J Gen Intern Med; 2018 Oct; 33(10):1621-1622. PubMed ID: 29882182
    [No Abstract]   [Full Text] [Related]  

  • 9. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to secondary prevention therapies in acute coronary syndrome.
    Thakkar JB; Chow CK
    Med J Aust; 2014 Nov; 201(10):S106-9. PubMed ID: 25390496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary coronary prevention in women: it starts with cardiac rehabilitation, exercise, and fitness.
    Lavie CJ; Milani R
    J Womens Health (Larchmt); 2009 Aug; 18(8):1115-7. PubMed ID: 19627237
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oxidative-reductive balance in patients after acute coronary syndrome that undergo cardiac rehabilitation].
    Matysiak R; Błaszczyk J; Obrebska A; Mejer A; Koziróg M; Kowalski J
    Pol Merkur Lekarski; 2014 Sep; 37(219):148-52. PubMed ID: 25345274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving patient adherence to secondary prevention medications 6 months after an acute coronary syndrome: observational cohort study.
    Brieger D; Chow C; Gullick J; Hyun K; D'Souza M; Briffa T;
    Intern Med J; 2018 May; 48(5):541-549. PubMed ID: 29345403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of calcium channel blockers with dual antiplatelet therapy and re-hospitalization for acute coronary syndrome.
    Wang CY; Lin ZF; Lee CM; Tsai YW; Huang TY; Shen LJ; Hsiao FY
    Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):229-238. PubMed ID: 28067454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary preventive medication use in a prevalent population-based cohort of acute coronary syndrome survivors.
    Gunnell AS; Hung J; Knuiman MW; Nedkoff L; Gillies M; Geelhoed E; Hobbs MS; Katzenellenbogen JM; Rankin JM; Ortiz M; Briffa TG; Sanfilippo FM
    Cardiovasc Ther; 2016 Dec; 34(6):423-430. PubMed ID: 27489053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study of adherence to European clinical practice guidelines for the management of acute coronary syndrome in revascularized versus non-revascularized patients - the CONNECT Study.
    Sabouret P; Asseman P; Dallongeville J; Dujardin JJ; Philippe F; Herrmann MA; Montalescot G;
    Arch Cardiovasc Dis; 2010; 103(8-9):437-46. PubMed ID: 21074122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry.
    Eccleston D; Horrigan M; Rafter T; Holt G; Worthley SG; Sage P; Whelan A; Reid C; Thompson PL
    Heart Lung Circ; 2017 Dec; 26(12):1303-1309. PubMed ID: 28389196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based prescribing of drugs for secondary prevention of acute coronary syndrome in Aboriginal and non-Aboriginal patients admitted to Western Australian hospitals.
    Gausia K; Katzenellenbogen JM; Sanfilippo FM; Knuiman MW; Thompson PL; Hobbs MS; Thompson SC
    Intern Med J; 2014 Apr; 44(4):353-61. PubMed ID: 24528930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Optimal Medical Therapy and Secondary Prevention in Patients after an Acute Coronary Syndrome].
    Stähli BE; Landmesser U
    Dtsch Med Wochenschr; 2018 May; 143(9):672-679. PubMed ID: 29684934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-adherence to medication and cardiovascular risk.
    Stewart RA; Kerr A
    N Z Med J; 2011 Sep; 124(1343):6-10. PubMed ID: 21964006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.